NextCell Pharma AB (FRA:65G) Long-Term Debt : €0.00 Mil (As of Aug. 2024)

View and export this data going back to 2020. Start your Free Trial

What is NextCell Pharma AB Long-Term Debt?

NextCell Pharma AB's Long-Term Debt for the quarter that ended in Aug. 2024 was €0.00 Mil.

NextCell Pharma AB Long-Term Debt Historical Data

The historical data trend for NextCell Pharma AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Long-Term Debt Chart

NextCell Pharma AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Long-Term Debt

Get a 7-Day Free Trial

NextCell Pharma AB Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	-	-

NextCell Pharma AB (FRA:65G) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

NextCell Pharma AB Long-Term Debt Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCell Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (FRA:65G) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

NXTCL:Sweden

Address

Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157

Website

http://www.nextcellpharma.com

NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB Headlines

No Headlines